Site Map

About Relmada

• Overview
• Corporate Strategy
• Management Team
• Scientific Advisory Board
• Publications

Pain Management

• Uncontrolled Pain
• Abuse Deterrence
• Pain Resources

Pain Market

• Chronic Pain
• Long Acting Opioids
• Lower Risk Opioids
• Neuropathic Pain
• Addiction Therapy

Development Pipeline

• Pipeline Overview
• REL-1015 (Levorphanol ER)
• REL-10xx (d-Methadone)
• REL-1021 (Topical Mepivacaine)
• REL-1028 (Oral Buprenorphine ER)

Investors

News

Careers

Contact Us

Terms of Use